![Nancy M. Wyant](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nancy M. Wyant
Corporate Officer/Principal chez
Linking Leaders, LLC
Profil
Nancy M.
Wyant is a member of the American Epilepsy Society and Linking Leaders, LLC.
She previously worked as a Senior Director-Global Clinical Operations at Shire Plc, Vice President & Head-Clinical Operations at Idera Pharmaceuticals, Inc., Sarepta Therapeutics, Inc., and Shire Human Genetic Therapies, Inc. She also worked as Vice President-Clinical Operations at BeiGene USA, Inc. and currently serves as Vice President & Head-Clinical Operations at Stoke Therapeutics, Inc. Ms. Wyant received her undergraduate degree from Hartwick College in 1993.
Postes actifs de Nancy M. Wyant
| Sociétés | Poste | Début |
|---|---|---|
Linking Leaders, LLC | Corporate Officer/Principal | - |
American Epilepsy Society
 American Epilepsy Society Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organisation for professionals dedicated to the prevention and treatment of epilepsy | Corporate Officer/Principal | - |
Anciens postes connus de Nancy M. Wyant
| Sociétés | Poste | Fin |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
BeiGene USA, Inc.
 BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Directeur Technique/Scientifique/R&D | 01/01/2018 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Directeur Technique/Scientifique/R&D | 01/06/2016 |
| SAREPTA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/05/2014 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Directeur Technique/Scientifique/R&D | 01/12/2012 |
Formation de Nancy M. Wyant
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Hartwick College
 Hartwick College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
American Epilepsy Society
American Epilepsy Society Miscellaneous Commercial ServicesCommercial Services Operates as non-profit organisation for professionals dedicated to the prevention and treatment of epilepsy | Commercial Services |
BeiGene USA, Inc.
BeiGene USA, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Linking Leaders, LLC |
